What amount sold does Jennison Global Healthcare Offshore Fund, Ltd. report in Form D filings?

The latest linked filings report $8.2M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Jennison Global Healthcare Offshore Fund, Ltd.'s most recent SEC filing?

Jennison Global Healthcare Offshore Fund, Ltd.'s most recent Form D filing was on 2026-10-09.

How many investors does Jennison Global Healthcare Offshore Fund, Ltd. have?

The most recent Form D filing lists 3 investor(s).

Jennison Global Healthcare Offshore Fund, Ltd.

CIK: 0001582260·Pooled Investment Fund·GRAND CAYMAN, E9·Corporation

Reported Sold

$8,241,000

Total Filings

Identified Offerings

Last Filed

Oct 9, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Oct 9, 2026Form D/A — Amendment

Reported sold: $8,241,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Sales commissions

Oct 10, 2025Form D/A — Amendment

Reported sold: $8,241,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Sales commissions

Oct 10, 2024Form D/A — Amendment

Reported sold: $8,241,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Sales commissions

Oct 11, 2023Form D/A — Amendment

Reported sold: $8,241,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Sales commissions

Oct 12, 2022Form D/A — Amendment

Reported sold: $8,241,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Reported investors, Sales commissions

Oct 15, 2021Form D/A — Amendment

Reported sold: $8,241,000 · Target: Indefinite

Rule 506(b)·6 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Aug 27, 2020Form D/A — Amendment

Reported sold: $7,991,000 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Sales commissions

Aug 27, 2019Form D/A — Amendment

Reported sold: $8,991,000 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Sales commissions

Aug 28, 2018Form D/A — Amendment

Reported sold: $8,891,000 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Sales commissions

Sep 1, 2017Form D/A — Amendment

Reported sold: $7,991,000 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(7)

Changed: Reported investors, Sales commissions

Sep 1, 2016Form D/A — Amendment

Reported sold: $7,991,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Sales commissions

Sep 8, 2015Form D/A — Amendment

Reported sold: $7,209,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Sales commissions

Sep 8, 2014Form D/A — Amendment

Reported sold: $7,209,000 · Target: Indefinite

Rule 506(b)·3 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions, Exemptions

Sep 12, 2013Form D/A — Amendment

Reported sold: $5,500,000 · Target: Indefinite

Rule 506·23 investors·Section 3(c), Section 3(c)(7)

Changed: Exemptions

Jul 29, 2013Form D — New notice

Reported sold: $5,500,000 · Target: Indefinite

Section 3(c)·23 investors·Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

$6,857

Amendment Rate

93%

Latest reported sold across 1 identified offering

$8,241,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Kenneth Moore

Related Person

Appears on 15 filings

Jennison Associates LLC

Related Person

Appears on 13 filings

Janice Vrdoljak

Related Person

Appears on 11 filings

Anthony Miele

Related Person

Appears on 6 filings

Leslie Rolison

Related Person

Appears on 5 filings

Mehdi Mahmud

Related Person

Appears on 4 filings

Lawrence Mohs

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 9, 2026	Amendment	Indefinite	$8,241,000	3
Oct 10, 2025	Amendment	Indefinite	$8,241,000	3
Oct 10, 2024	Amendment	Indefinite	$8,241,000	3
Oct 11, 2023	Amendment	Indefinite	$8,241,000	3
Oct 12, 2022	Amendment	Indefinite	$8,241,000	3
Oct 15, 2021	Amendment	Indefinite	$8,241,000	6
Aug 27, 2020	Amendment	Indefinite	$7,991,000	2
Aug 27, 2019	Amendment	Indefinite	$8,991,000	2
Aug 28, 2018	Amendment	Indefinite	$8,891,000	2
Sep 1, 2017	Amendment	Indefinite	$7,991,000	2
Sep 1, 2016	Amendment	Indefinite	$7,991,000	3
Sep 8, 2015	Amendment	Indefinite	$7,209,000	3
Sep 8, 2014	Amendment	Indefinite	$7,209,000	3
Sep 12, 2013	Amendment	Indefinite	$5,500,000	23
Jul 29, 2013	New	Indefinite	$5,500,000	23

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Pavreta Master Fund LP

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 29, 2026